KOPRAN
Back to All Ratios
|
KOPRAN Last 5 Year EV/EBIT History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
EV/EBIT(x) | 17.48 | 14.12 | 15.82 | 5.73 | 5.19 |
What is the latest EV/EBIT ratio of KOPRAN ?
Year | EV/EBIT |
---|---|
Mar2024 | 17.48 |
Mar2023 | 14.12 |
Mar2022 | 15.82 |
Mar2021 | 5.73 |
Mar2020 | 5.19 |
How is EV/EBIT of KOPRAN Trending?
Years | EV/EBIT | % Change | |
---|---|---|---|
Mar2024 | 17.48 | 23.80 | |
Mar2023 | 14.12 | -10.75 | |
Mar2022 | 15.82 | 176.09 | |
Mar2021 | 5.73 | 10.40 | |
Mar2020 | 5.19 | - |
Other Financial Ratios of KOPRAN
Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare EV/EBIT ratio of peers of KOPRAN
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
KOPRAN | ₹1,544.1 Cr | 11.4% | 6.2% | 35.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹438,418.0 Cr | -1.2% | -4.7% | 58.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹157,680.0 Cr | 0.8% | 7.1% | 73.4% | Stock Analytics | |
CIPLA | ₹128,755.0 Cr | 2.7% | -2.8% | 32.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹108,720.0 Cr | 2.3% | -2.2% | 20.9% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹100,120.0 Cr | -0.7% | -5.6% | 69.2% | Stock Analytics |
KOPRAN Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
KOPRAN | 11.4% |
6.2% |
35.6% |
SENSEX | 0.6% |
-0.8% |
25.4% |
You may also like the below Video Courses